All lectures are on Tuesdays from 12 to 1 p.m. in Comer Commons at Moores Cancer Center (directions and map). Lunch is available at 11:40 a.m. for those attending the lecture.
Principles of Cancer Drug Therapeutics Development
This is a series of weekly lectures delivered by CT2 and UC San Diego faculty members focusing on the necessary sequential steps involved in drug development.
Topics in Cancer Drug Development
This is a series of lectures by industry leaders in cancer drug development. The goal is to expose trainees to experts with a substantial track record in the “real life” challenges of cancer drug development. The lecturers are typically CEOs, directors of research, or medical directors from companies in the San Diego biomedical community, although experts from large pharmaceutical companies have also participated. The outside speakers are invited to discuss challenges of developing a given target or novel therapeutic and give fellows an opportunity to hear the story of the development of specific therapeutic agents.
Upcoming Lectures
11/19/19
| (Speaker Postponed)
| UCSD
| Angiogenesis
| Comer Commons
|
11/26/19
| Michael Bouvet, MD
| UCSD
| Development of Imaging Probes for Fluorescence Guided Surgery
| Comer Commons
|
12/3/19
| Jing Yang, PhD
| UCSD
| Epithelial-Mesenchymal Plasticity in Carcinoma Metastasis | Comer Commons
|
12/10/2019
| Reuben Shaw, PhD
| Salk
| LKB1/STK11 mutant lung cancer: from pathways to drug targets
| Comer Commons
|
12/17/19
| William Gerwick, PhD
| SIO
| Ocean Life as a Source of Novel Anticancer Drugs: Updates and New Developments
| Comer Commons |
1/7/2020
| Nicole Steinmetz, PhD
| UCSD | NanoEngineering Gone Viral: Plant Virus-based Immunotherapies
| Comer Commons |
1/14/2020
| Aaron Miller, MD
| UCSD | Functional identification and therapeutic targeting of neoantigens in patients with solid tumors
| Comer Commons
|
1/21/2020
| Gerald Joyce, MD, PhD
| Novartis
| Drug Discovery across the Street at GNF | Comer Commons
|
1/28/2020
| Christian Metallo, PhD
| UCSD
| Influence of Serine Availability on Tumor Lipid Metabolism
| Comer Commons
|
Schedules for previous years